{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:22:12Z","timestamp":1761844932718,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jcv.2018.09.016","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T02:00:17Z","timestamp":1538013617000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5157","authenticated-orcid":false,"given":"Seiya","family":"Yamayoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuhiro","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Uraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2018.09.016_bib0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/MMBR.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.jcv.2018.09.016_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","article-title":"Bat-derived influenza-like viruses H17N10 and H18N11","volume":"22","author":"Wu","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jcv.2018.09.016_bib0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2018.09.016_bib0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jcv.2018.09.016_bib0025","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1038\/ncomms8708","article-title":"A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus","volume":"6","author":"Wu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jcv.2018.09.016_bib0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","article-title":"An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies","volume":"14","author":"Nakamura","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcv.2018.09.016_bib0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jcv.2018.09.016_bib0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ebiom.2017.03.007","article-title":"A broadly reactive human anti-hemagglutinin stem monoclonal antibody that inhibits influenza a virus particle release","volume":"17","author":"Yamayoshi","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jcv.2018.09.016_bib0045","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza a subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2018.09.016_bib0050","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/JVI.03069-14","article-title":"Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies","volume":"89","author":"Wyrzucki","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2018.09.016_bib0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-induced antibodies that neutralize group 1 and group 2 influenza a viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2018.09.016_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080034","article-title":"Mechanisms of hemagglutinin targeted influenza virus neutralization","volume":"8","author":"Brandenburg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2018.09.016_bib0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jcv.2018.09.016_bib0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jcv.2018.09.016_bib0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.1400432","article-title":"Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine","volume":"193","author":"Jegaskanda","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcv.2018.09.016_bib0080","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of Fc-Fc\u03b3R interactions in IgG-mediated microbial neutralization","volume":"212","author":"Bournazos","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jcv.2018.09.016_bib0085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume":"15","author":"Pincetic","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jcv.2018.09.016_bib0090","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.19.30533","article-title":"Biological characterisation of the emerged highly pathogenic avian influenza (HPAI) A(H7N9) viruses in humans, in mainland China, 2016 to 2017","volume":"22","author":"Zhu","year":"2017","journal-title":"Euro surveill."},{"key":"10.1016\/j.jcv.2018.09.016_bib0095","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3201\/eid2308.170600","article-title":"Human infection with highly pathogenic avian influenza a(H7N9) virus, China","volume":"23","author":"Ke","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jcv.2018.09.016_bib0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jinf.2017.04.001","article-title":"Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China","volume":"75","author":"Zhang","year":"2017","journal-title":"J. Infect."},{"key":"10.1016\/j.jcv.2018.09.016_bib0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jcv.2018.09.016_bib0110","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jcv.2018.09.016_bib0115","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2018.09.016_bib0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jcv.2018.09.016_bib0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1073\/pnas.1319058110","article-title":"A common solution to group 2 influenza virus neutralization","volume":"111","author":"Friesen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2018.09.016_bib0130","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI74374","article-title":"Preexisting human antibodies neutralize recently emerged H7N9 influenza strains","volume":"125","author":"Henry Dunand","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jcv.2018.09.016_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028001","article-title":"A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes","volume":"6","author":"Clementi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2018.09.016_bib0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jinf.2017.12.004","article-title":"Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human","volume":"76","author":"Yamayoshi","year":"2018","journal-title":"J. Infect."},{"key":"10.1016\/j.jcv.2018.09.016_bib0145","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbrc.2009.06.151","article-title":"Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors","volume":"387","author":"Kubota-Koketsu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jcv.2018.09.016_bib0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.virusres.2011.03.022","article-title":"Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice","volume":"158","author":"Sakabe","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.jcv.2018.09.016_bib0155","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2018.09.016_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025848","article-title":"Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties","volume":"6","author":"Strengell","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2018.09.016_bib0165","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.meegid.2011.03.015","article-title":"Evolutionary dynamics of the influenza A pandemic (H1N1) 2009 virus with emphasis on Indian isolates: evidence for adaptive evolution in the HA gene","volume":"11","author":"Mullick","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.jcv.2018.09.016_bib0170","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.42.19692-en","article-title":"A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore","volume":"15","author":"Barr","year":"2010","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jcv.2018.09.016_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005702","article-title":"Two escape mechanisms of influenza a virus to a broadly neutralizing stalk-binding antibody","volume":"12","author":"Chai","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcv.2018.09.016_bib0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13567-017-0484-8","article-title":"Glycosylation at 11Asn on hemagglutinin of H5N1 influenza virus contributes to its biological characteristics","volume":"48","author":"Yin","year":"2017","journal-title":"Vet. Res."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218302518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653218302518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T04:49:45Z","timestamp":1605070185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653218302518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":36,"alternative-id":["S1386653218302518"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2018.09.016","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2018.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}